Dr. Halpern is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
228 Park Avenue South
New York, NY 10003Phone+1 917-503-9148- Is this information wrong?
Summary
- Dr. Joshua Halpern MD MS is a board-certified and fellowship-trained Reproductive Urologist practicing in New York and throughout the Northeast. He serves as both the Regional Medical Director in the Northeast and Chief Scientific Officer for Posterity Health. He is also on faculty at Northwestern University Feinberg School of Medicine.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2013 - 2018
- Weill Cornell Graduate School of Medical SciencesMS, Health Policy and Economics, 2015 - 2016
- New York Presbyterian Hospital (Cornell Campus)Internship, Surgery, 2012 - 2013
- Weill Cornell MedicineClass of 2012, MD, Alpha Omega Alpha
Certifications & Licensure
- RI State Medical License 2024 - 2026
- IL State Medical License 2018 - 2026
- CO State Medical License 2024 - 2025
- DE State Medical License 2023 - 2025
- NY State Medical License 2016 - 2025
- NJ State Medical License 2023 - 2025
- NH State Medical License 2023 - 2025
- American Board of Urology Urology
- Join now to see all
Publications & Presentations
PubMed
- Editorial Comment.Kian Asanad, Joshua A Halpern> ;The Journal of Urology. 2024 May 1
- Distribution and Positive Predictive Value of Follicle Stimulating Hormone (FSH) Levels Among Non-azoospermic Men.Sai Kaushik Sr Kumar, Xinlei Mi, Solomon Hayon, Daniel Greenberg, Richard J Fantus, Robert E Brannigan, Joshua A Halpern> ;The Journal of Urology. 2024 Apr 11
- Prevalence of infertility and barriers to family building among male physicians.Jasmine S Lin, Jonathan Aguiar, Justin M Dubin, Robert E Brannigan, Joshua A Halpern> ;Andrology. 2024 Apr 10
- Join now to see all
Press Mentions
- Health News | Online Platforms Give Access to Testosterone Therapy Without Caution: StudyDecember 5th, 2022
- Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone TherapyDecember 5th, 2022
- Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone TherapyDecember 4th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: